Eisai has named longtime pharma communicator Robert Laverty to the newly created position of VP of US communications.
Laverty joins Eisai from Novartis, where he served as VP, global communications, malaria initiatives.
A 22-year industry veteran, Laverty has previously held several other executive titles at Novartis including VP, external communication and VP, global pharma media relations.
Prior to joining Novartis, Laverty worked in several corporate policy, corporate affairs, and product public affairs positions at Bristol-Myers Squibb Company.
